Cell Robotics' Lasette Receives 1999 Photonics Circle of Excellence Award; Lasette chosen as one of the 25 most technically innovative new products of the year.

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--May 19, 1999--

Cell Robotics International Inc. (OTC BB: CRII), Wednesday announced that its Lasette laser finger perforator was declared a winner of "The Photonics Circle of Excellence Award" in the May, 1999 issue of Photonics Spectra, a highly-respected laser publication.

The Circle of Excellence Award recognizes the 25 most technically innovative new products of the year.

According to Photonics Spectra, "for more than a decade, these annual awards have recognized the enterprising companies and individuals that have refused to accept the status quo and have instead pushed the limits of technology to develop new photonic products and processes.

"This year's 25 winning products ...were chosen from among the hundreds of entries submitted from around the world. They have survived the toughest scrutiny: judgment by the members of Photonics Spectra's Editorial Advisory Board - a true panel of recognized experts in a variety of disciplines."

The publication further stated, "Cell Robotics International Inc. has developed the first Class IV medical laser device available for performance of a routine procedure by non-specialists in the clinical environment.

"This Albuquerque, N.M. company's Lasette laser skin perforator represents a milestone in the evolution of laser products by providing greater accessibility of laser technology to the general public.

"The Lasette is a portable single-pulsed Erbium:YAG laser device that ablates a small hole in the fingertip to permit access to capillary blood so that procedures such as glucose testing can be performed ... which is performed more that a billion times a year."

Since applying for "The Circle of Excellence Award", Cell Robotics has received FDA clearance for the use of the Lasette in the home. This allows diabetics to sample their blood for glucose measurements in a nearly painless manner. The Lasette is marketed and sold by Chronimed (Nasdaq: CHMD).

In addition to the Lasette, Cell Robotics has developed, manufactures, markets, and sells the In Vitro Fertilization (IVF) Workstation designed to increase pregnancy rates for IVF fertility treatments and the Cell Robotics Workstation, a research instrument that incorporates the LaserTweezers(R) and LaserScissors(TM) for manipulating and cutting cells and chromosomes.

Additional information is available on the Cell Robotics Web Site at http://www.cellrobotics.com, by e-mail at [e-mail]., or by telephone at 505/343-1131.

As a cautionary note to investors, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; the company's ability to execute its service and product sales plans; and the risks described from time to time in the company's Securities and Exchange Commission filings.